Top compounds associated with response to CES5A


Feature Type Standardized
Nominal ANOVA
mRNA thalidomide CTRPv2 pan-cancer AAC -0.045 0.4
mRNA KIN001-270 GDSC1000 pan-cancer AAC -0.029 0.4
mRNA leptomycin B CTRPv2 pan-cancer AAC 0.028 0.4
mRNA lenvatinib CTRPv2 pan-cancer AAC 0.031 0.4
mRNA Cisplatin GDSC1000 pan-cancer AAC 0.029 0.4
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.028 0.4
mRNA VX-680 GDSC1000 pan-cancer AAC -0.044 0.4
mRNA FQI-1 CTRPv2 pan-cancer AAC 0.039 0.4
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.029 0.4
mRNA Vorinostat GDSC1000 pan-cancer AAC -0.026 0.4
Download CSV